How To Use CPT Code 90378

CPT 90378 describes the administration of respiratory syncytial virus immune globulin (RSV-Ig) through intramuscular injection. This article will cover the description, procedure, qualifying circumstances, appropriate usage, documentation requirements, billing guidelines, historical information, similar codes and billing examples.

1. What is CPT Code 90378?

CPT 90378 can be used to describe the administration of respiratory syncytial virus immune globulin (RSV-Ig) through intramuscular injection. This code is used when a healthcare provider slowly administers 50 mg injections of RSV-Ig into the patient’s muscle using an appropriately sized needle. The purpose of this procedure is to provide short-term immunity during the peak infective period of the respiratory syncytial virus.

2. Official Description

The official description of CPT code 90378 is: ‘Respiratory syncytial virus, monoclonal antibody, recombinant, for intramuscular use, 50 mg, each.’

3. Procedure

1. The healthcare provider selects an appropriately sized needle and prepares the respiratory syncytial virus immune globulin (RSV-Ig) for injection.
2. The provider administers a 50 mg injection of RSV-Ig into the patient’s muscle using the selected needle.
3. The injection is performed once a month to provide short-term immunity during the peak infective period of the respiratory syncytial virus.

4. Qualifying circumstances

This procedure is performed on patients who require short-term immunity against the respiratory syncytial virus. The patient must be under the care of a healthcare provider who is qualified to administer intramuscular injections. The provider must administer 50 mg injections of respiratory syncytial virus immune globulin (RSV-Ig) using an appropriately sized needle.

5. When to use CPT code 90378

CPT code 90378 should be used when a healthcare provider administers a 50 mg injection of respiratory syncytial virus immune globulin (RSV-Ig) through intramuscular injection. This code should be reported for each 50 mg injection performed.

6. Documentation requirements

To support a claim for CPT 90378, the healthcare provider must document the following information:

• Patient’s diagnosis and the need for respiratory syncytial virus immune globulin (RSV-Ig) administration
• Date of the injection
• Start and end time of the procedure
• Amount of respiratory syncytial virus immune globulin (RSV-Ig) administered (50 mg)
• Signature of the healthcare provider performing the procedure

7. Billing guidelines

When billing for CPT 90378, ensure that the healthcare provider administering the injection is qualified to perform intramuscular injections. Use the appropriate CPT code for each 50 mg injection performed. Report CPT code 90378 separately and do not report it with other codes.

8. Historical information

CPT 90378 was added to the Current Procedural Terminology system on January 1, 2000. There have been no updates or changes to the code since its addition.

9. Examples

1. A healthcare provider administering a 50 mg injection of respiratory syncytial virus immune globulin (RSV-Ig) through intramuscular injection to a patient with a high risk of respiratory syncytial virus infection.
2. A nurse slowly administering a 50 mg injection of respiratory syncytial virus immune globulin (RSV-Ig) through intramuscular injection to an infant during the peak infective period of the virus.
3. A physician administering a 50 mg injection of respiratory syncytial virus immune globulin (RSV-Ig) through intramuscular injection to a patient with a compromised immune system.
4. A healthcare provider performing a 50 mg injection of respiratory syncytial virus immune globulin (RSV-Ig) through intramuscular injection to a premature baby at risk of respiratory syncytial virus infection.
5. A nurse administering a 50 mg injection of respiratory syncytial virus immune globulin (RSV-Ig) through intramuscular injection to an elderly patient during the respiratory syncytial virus season.
6. A healthcare provider administering a 50 mg injection of respiratory syncytial virus immune globulin (RSV-Ig) through intramuscular injection to a patient with a history of severe respiratory syncytial virus infection.
7. A nurse slowly injecting a 50 mg dose of respiratory syncytial virus immune globulin (RSV-Ig) through intramuscular injection to a child with chronic lung disease.
8. A physician administering a 50 mg injection of respiratory syncytial virus immune globulin (RSV-Ig) through intramuscular injection to a patient with a weakened immune system.
9. A healthcare provider performing a 50 mg injection of respiratory syncytial virus immune globulin (RSV-Ig) through intramuscular injection to a patient with a heart condition.
10. A nurse administering a 50 mg injection of respiratory syncytial virus immune globulin (RSV-Ig) through intramuscular injection to a patient with a lung transplant.